Navigation Links
PhRMA Statement Supporting Fair Incentives for Biologics Innovation
Date:10/19/2009

age-associated infirmities ... [A] well-defined process for approving biosimilars will help sustain investment in this vital area of therapy development and allow for these treatments to one day be made widely available to patients who otherwise could not have access to them.' -- Alliance for Aging Research

"Creating a new biologic medicine is a complex, long-term endeavor that is costly, takes years of research, and has an uncertain chance of success. Development costs for innovative biologics alone can exceed $1.2 billion, plus up to an additional $450 million to build specialized manufacturing facilities.

"Already, many biotechnology companies that are the birthplace for many cutting-edge therapies face a bleak outlook. The recent financial crisis, for some, represented a deadly blow. Twenty-two biotechs have already been delisted from NASDAQ. This week, NVCA and Thomson Reuters reported that venture capital funds raised in the third quarter of 2009 plummeted to the lowest level in 15 years.

"R&D is the engine that drives continued medical advances that save lives and improve patients' quality of life, but few would tackle biologic medicines without a fighting chance to recoup their significant investments.

"Importantly, if we're going to cure cancer in our lifetime, as President Obama has challenged America to do, new innovative biologics, undoubtedly, will play an instrumental role."

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PhRMA Statement on Senate Finance Committee Vote
2. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
3. SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
4. EAU Position Statement on Screening for Prostate Cancer
5. Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients
6. A Joint Statement From Americas Prostate Cancer Advocacy, Education, and Support Organizations
7. Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients
8. American Heart Association Scientific Statement: Heart Patients Should Be Screened, Treated for Depression
9. Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm
10. VA Statement on Smoking Cessation Research Program
11. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... VIENNA , March 5, 2015 ... announce the new generation of OASIS *    ... with enhanced processing power will set a benchmark for ... overcome obstacles and prevent delays whilst optimizing workflow management ... quality, patient comfort and safety for imaging in Neurology, ...
(Date:3/5/2015)... MENLO PARK, Calif. , March 5, 2015 /PRNewswire/ ... company in the emerging field of regenerative medicine, announced ... one of the nation,s top rehabilitation hospitals for spinal ... the Phase 1/2a clinical trial of AST-OPC1 (oligodendrocyte progenitor ... complete cervical spinal cord injury (SCI). ...
(Date:3/5/2015)... Denmark , March 5, 2015 ... that applies its innovative TransCon technology to address ... present two posters at the ENDO 2015 conference ... The posters will be presented on Thursday, March ... is being held from 1:00pm-3:00pm PST, and are ...
Breaking Medicine Technology:Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4Ascendis Pharma to Present at ENDO 2015 2
... , , ATLANTA , Feb. ... Board: GOVX) (the "Company"), an Atlanta -based, biopharmaceutical company ... Virus) and other infectious agents, today provided an update on ... grow at an alarming rate, 60,000 new infections annually, and ...
... , ABBOTT PARK, Ill., Feb. 8 A new ... common form of ovarian cancer may soon be available in ... a simple blood test to help in monitoring for the recurrence ... would be the first automated HE4 test available in the ...
Cached Medicine Technology:GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 2GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 3GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 4GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 5GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDA 6Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval 2Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval 3
(Date:3/5/2015)... The global digital PCR (dPCR) and qPCR market is expected ... 2014 to 2019. , The global digital PCR (dPCR) and qPCR ... 2014 to 2019. Although the mature markets such as the U.S., ... (dPCR) and qPCR market the Asia-Pacific region is expected to grow ... growth of the digital PCR (dPCR) and qPCR market is driven ...
(Date:3/5/2015)... FL (PRWEB) March 05, 2015 ... company focused on the peripheral nerve repair market, reported ... ended December 31, 2014 compared to $2.98 million in ... of its growth strategies. , “Our strong fourth ... our peripheral nerve repair products which is driving increased ...
(Date:3/5/2015)... Rhode Island Medical Imaging (RIMI) was pleased to donate ... the Providence College (PC) women’s basketball program’s fight to end ... ‘Think Pink’ uniforms, which were worn during the February 22nd ... at Alumni Hall/Mullaney Gymnasium in Providence, R.I. , ... women’s basketball’s ‘Pink Out’ event,” said Dr. Scott Levine of ...
(Date:3/5/2015)... SuperCloset has released a new video series called ... teach viewers everything they need to know about how to ... takes you from seed all the way through harvest, and ... to prune Grow Like a SuperPro will help take the ... for download for a special introductory price of $19.95. Or ...
(Date:3/5/2015)... March 05, 2015 HMP ... healthcare communications and education, announced today its acquisition ... the nation’s only medical conference designed for health ... and lower limb amputation due to vascular disorders. ... of innovative, evidence-based publications and CME activities across ...
Breaking Medicine News(10 mins):Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:RIMI Teams Up with PC Women’s Basketball in the Fight Against Breast Cancer 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3
... still may benefit from HPV vaccine, study finds , TUESDAY, ... works for women aged 24 to 45 who aren,t already ... cervical cancer and other cervical diseases. , That,s the finding ... in Bogota, Columbia, who noted that women,s rising age at ...
... that a deficiency in a key tumor suppressor gene in the ... The study, conducted in mice that mimic human cancer, points the ... for the disease early. Appearing June 2 in Cancer ... first time that:, Glioblastoma, the type of cancer that afflicts ...
... Minn. -- Mayo Clinic researchers have demonstrated that a noninvasive ... the common cancers above the colon -- including pancreas, stomach, ... 100 Mayo Clinic studies being presented at Digestive Disease Week ... Gastrointestinal (GI) cancers account for approximately one in four cancer ...
... 2009 A closer look at regulatory and clinical ... required, according to an educational advisory by the International ... July 2009 issue of The Journal of Heart ... Elsevier. Thoracic ...
... syndrome results from prolonged flexing of the elbow, experts say ... Nintendo thumb. Then, Guitar Hero wrist. Now, for the latest ... Medically known as cubital tunnel syndrome, cell phone elbow is ... by compression of the ulnar nerve, which passes along the ...
... to use a new, cutting edge diagnostic technology ... , , WOBURN, Mass., and VEDBAEK, Denmark, June ... Center in Savannah, Georgia has implemented AdvanDx,s PNA FISH(R) tests ... conventional methods to help their physicians, pharmacists and nurses improve ...
Cached Medicine News:Health News:Cervical Cancer Vaccine Not Just for Teens 2Health News:Most common brain cancer may start in neural stem cells 2Health News:Most common brain cancer may start in neural stem cells 3Health News:Most common brain cancer may start in neural stem cells 4Health News:Improved DNA stool test could detect digestive cancers in multiple organs 2Health News:Improved DNA stool test could detect digestive cancers in multiple organs 3Health News:More stringent evaluation on the use of generic medications in thoracic transplantation 2Health News:'Cell Phone Elbow' -- A New Ill for the Wired Age 2Health News:'Cell Phone Elbow' -- A New Ill for the Wired Age 3Health News:Memorial University Medical Center (MUMC) Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections 2Health News:Memorial University Medical Center (MUMC) Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections 3
... Prefab Orthosis For quick, efficient immobilization ... shell immobilizes and protects the fracture ... adds comfort, support, and conformity to ... the shell may be gently heated ...
Finger /Thumb Splint has a stay that may be shaped to hold finger or thumb in exact degree of flexion. It also has a contact closure....
Combination Oppenheimer with Knuckle Bender - to dorsiflex wrist and flex MCP joints; includes two attachments to extend/flex distal finger joints....
Bunell Mini-Modified Safety Finger Pin reduces PIP flexion contractures....
Medicine Products: